Infliximab 57894-0160
Product NDC
57894-0160- Manufacturer
- Janssen Biotech, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 5, 2021
- Listing Expires
- December 31, 2027
- Application
- BLA103772
Need to source Infliximab? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Infliximab | 100 mg/10mL |
Drug Class
Tumor Necrosis Factor Blocker [EPC]Tumor Necrosis Factor Blocker [EPC]Tumor Necrosis Factor Receptor Blocking Activity [MoA]
Packaging Options(1)
1 VIAL, SINGLE-USE in 1 BOX (57894-160-01) / 10 mL in 1 VIAL, SINGLE-USE